A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor

Completed

Conditions studied: Preterm Birth

In brief

Prospective multicenter observational study to further develop and validate a preterm birth risk predictor, using a preterm cutoff at 37 0/7 weeks gestation and at 35 0/7 weeks gestation. A single maternal peripheral blood sample will be collected for analysis. Data related to potential risk factors for preterm birth will be obtained through maternal interview and review of medical records. Subjects will be followed through the delivery process to assess the course of pregnancy, labor, and to document any related maternal complications. Neonatal outcomes will be gathered from the medical record for up to 28 days of life or discharge, whichever occurs first.

Key facts

Study ID

NCT02787213

Run by

Sera Prognostics, Inc.

People needed

5011

Starts

2016-08-01

Expected to finish

2019-06-01

Last updated by the study team

2021-04-14

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Subject is 18 years of age or older
• Subject has singleton gestation
• Subject is able to provide consent
• Gestational age is confirmed by a documented crown rump length on an ultrasound performed at the study site within 6 0/7 weeks and 13 6/7 weeks gestation (first trimester)
• Subject has no signs and/or symptoms of preterm labor and has intact membranes
• Investigator believes subject is willing to comply with study visits and procedures
• Investigator believes the subject's delivery data will be available within 15 business days from delivery, and neonatal data will be available for data collection purposes within 15 business days from discharge

You may not qualify if…

• The subject has a planned cesarean section or induction of labor prior to 370/7 weeks of gestation
• The subject has a planned cerclage placement for the current pregnancy
• There is a known or suspected fetal anomaly or chromosomal abnormality
• The subject has had a blood transfusion during the current pregnancy
• The subject has known elevated bilirubin levels (hyperbilirubinemia)
• The subject has taken or plans to take any of the following medications during the current pregnancy:
• Progesterone or progesterone-derivative medication after 13 6/7 weeks gestation
• Enoxaparin, heparin, heparin sodium, low molecular weight heparin after first day of last menstrual period
• The subject has participated in, or plans to participate in, an interventional treatment study during the current pregnancy
• The current pregnancy was previously a multiple gestation that is now a single fetus due to reduction, vanishing twin, etc.

Where it is running

• Maricopa Integrated Health Systems — Phoenix, Arizona, United States
• University of California, Irvine Medical Center — Orange, California, United States
• UC San Diego Health — San Diego, California, United States
• University of Colorado-Denver — Aurora, Colorado, United States
• Denver Health Medical Center — Denver, Colorado, United States
• Northwestern Memorial Hospital — Chicago, Illinois, United States
• Indiana University Medical Center — Indianapolis, Indiana, United States
• Ochsner Baptist Medical Center — New Orleans, Louisiana, United States
• Boston Medical Center — Boston, Massachusetts, United States
• Baystate Medical Center — Springfield, Massachusetts, United States
• University of North Carolina — Chapel Hill, North Carolina, United States
• Duke University Medical Center — Durham, North Carolina, United States
• Oregon Health & Sciences University — Portland, Oregon, United States
• Thomas Jefferson University Hospital — Philadelphia, Pennsylvania, United States
• Medical University of South Carolina — Charleston, South Carolina, United States
• Greenville Health System — Greenville, South Carolina, United States
• Regional Obstetrical Consultants — Chattanooga, Tennessee, United States
• University of Texas Medical Branch — Galveston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.